Haroon Khan*, Sumaira Khattak, Mohammad S. Mubarak, Saud S. Bawazeer, Tareq Abu-Izneid and Mohammad A. Kamal Pages 9 - 13 ( 5 )
Background & Objective: Clinical depression is an unsatisfactory mood disorder affecting millions of people worldwide. The disorder is associated with a phenomenal number of suicidal attempts each year, and it has been estimated that 10-20 million people around the world made an attempt of suicide in some stage of the disease. Thus, medicinal intervention is ultimately required to avoid such type of extreme outcomes. There are numerous therapeutic antidepressant options in clinical practice, however, most of them face the challenge of efficacy, side effects, and patient compliance. In this scenario, new effective and safe therapeutic agents are becoming the major focus of researchers in the area of neuropharmacology, who and are evaluating different sources such as synthetic and natural therapeutics. Similarly, thousands of peptides have already shown vital role in human physiology for regulation of different activities.
Conclusion: This mini-review will focus on peptides with reported antidepressant activity, along with their mechanism of action. Furthermore, the present article summarizes the literature pertaining to these peptides as antidepressant agents.
Antidepressant potential, future prospects, limitations, mechanism, peptides, therapeutic.
Department of Pharmacy, Abdul Wali Khan University, Mardan, 23200, Department of Pharmacy, Abdul Wali Khan University, Mardan, 23200, Department of Chemistry, The University of Jordan, Amman, 11942, Department of Pharmaceutical Sciences, Faculty of Pharmacy Umm Al- Qura University, Makkah, P.O. Box 42, Department of Pharmaceutical Sciences, Faculty of Pharmacy Umm Al- Qura University, Makkah, P.O. Box 42, King Fahd Medical Research Center, King Abdulaziz University, P. O. Box 80216, Jeddah 21589